Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.47 |
| ▸ | PLAU | P00749 | 1/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.41 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.39 |
| ▸ | RELA | Q04206 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.39 |
| ▸ | COMT | P21964 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30375140 | 1.00 | NOTUM (0.48) | NOTUMIDO1PLAUPIK3CAALDH1A1 | |
| SCHEMBL20958107 | 0.98 | ALDH1A1 (0.46) | NOTUMIDO1PLAUPIK3CAALDH1A1 | |
| SCHEMBL22912663 | 0.88 | IDO1 (0.55) | IDO1PLAUALDH1A1SMN1; SMN2BUB1 | |
| Tetrahydrofuran SCHEMBL27539541 | 0.86 | IDO1 (0.38) | NOTUMIDO1PLAUPIK3CAFDPS | |
| SCHEMBL28460649 | 0.84 | LMNA (0.52) | NOTUMIDO1PIK3CA | |
| SCHEMBL17445451 | 0.79 | CYP11B1 (0.50) | IDO1ALDH1A1NISCHNPC1NFKB1 | |
| SCHEMBL16341603 | 0.79 | CYP2A6 (0.58) | IDO1PIK3CAALDH1A1SMN1; SMN2 | |
| SCHEMBL25397821 | 0.78 | MAP4K4 (0.46) | IDO1PIK3CAALDH1A1 | |
| SCHEMBL28582294 | 0.78 | IDO1 (0.44) | IDO1PLAUALDH1A1SMN1; SMN2 | |
| SCHEMBL27955461 | 0.78 | ESR1 (0.46) | IDO1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 217 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122029158-A | EGFR inhibitors | 缆图药品公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260059935-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-02-26 | — | — | US | disclosed |
| US-12528833-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2026-01-20 | — | — | US | disclosed |
| US-12415951-B2 | Organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-09-16 | — | — | US | disclosed |
| EP-3425690-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-06-11 | — | — | EP | disclosed |
| US-12286448-B2 | Organometallic compound, organic light-emitting device including oranometallic compound, and diagnostic composition including organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-04-29 | — | — | US | disclosed |
| CN-119143812-B | Phosphorescent iridium complex with inherent chiral structure, luminescent material, organic electroluminescent device and electronic equipment | 季华实验室 | 2025-04-01 | — | — | CN | disclosed |
| EP-3439063-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-03-26 | — | — | EP | disclosed |
| CN-115322229-B | Organic electrophosphorescent luminescent material and application thereof | 北京云基科技股份有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119143812-A | Phosphorescent iridium complex with inherent chiral structure, luminescent material, organic electroluminescent device and electronic equipment | 季华实验室 | 2024-12-17 | — | — | CN | disclosed |
| US-20030085646-A1 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2003-05-08 | — | — | US | disclosed |
| US-20030068536-A1 | Such as bis(4-biphenyl-4-yl)pyridine-C3-N3)(acetylacetonato-) iridium (III); brightness; phosphorescence; graphic arts | CANON KABUSHIKI KAISHA (JP) | 2003-04-10 | — | — | US | disclosed |
| US-20030065208-A1 | Using palladium, nickel phosphine complex as catalysts | MITSUBISHI RAYON CO., LTD. (JP) | 2003-04-03 | — | — | US | disclosed |
| EP-1270582-A1 | TRIPHENYLPHOSPHINE DERIVATIVE, PRODUCTION PROCESS THEREFOR, PALLADIUM COMPLEX THEREOF, AND PROCESS FOR PRODUCING BIARYL DERIVATIVE | Mitsubishi Rayon Co., Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-1244155-A2 | Metal coordination compound, luminescence device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2002-09-25 | — | — | EP | disclosed |
| EP-1239526-A2 | Metal coordination compound, luminescene device and display apparatus | CANON KABUSHIKI KAISHA (JP) | 2002-09-11 | — | — | EP | disclosed |
| US-4410530-A | CARDIO-SELECTIVE B-RECEPTOR BLOCKING AGENTS AND STIMULANTS | CIBA-GEIGY CORPORATION (US) | 1983-10-18 | — | — | US | disclosed |
| US-4291165-A | DIAZOTIZATION-BROMINATION OF 2-AMINOPYRIDINE WITH HYDROGEN BROMIDE IN THE PRESENCE OF BROMINE AND SULFURIC ACID | OLIN CORPORATION (US) | 1981-09-22 | — | — | US | disclosed |
| US-4195090-A | ADRENERGIC BLOCKING AGENTS | CIBA-GEIGY CORPORATION (US) | 1980-03-25 | — | — | US | disclosed |
| US-4115575-A | CARDIOVASCULAR DISORDERS | CIBA-GEIGY CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260059935-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | SOD1, OCIAD2, OCIAD1 | NOTUM 1861/4885IDO1 1463/4885PLAU 1630/4885 |
| US-20030065208-A1 | Using palladium, nickel phosphine complex as catalysts | PDCD1LG2, PIK3CA, PDCD1 | NOTUM 226/4885IDO1 1439/4885PLAU 4291/4885 |
| US-20030085646-A1 | Metal coordination compound, luminescence device and display apparatus | CYC1, CCNL2, LEF1 | NOTUM 4025/4885IDO1 348/4885PLAU 3768/4885 |
| US-12286448-B2 | Organometallic compound, organic light-emitting device including oranometallic compound, and diagnostic composition including organometallic compound | ORC3, ORMDL3, OCIAD1 | NOTUM 798/4885IDO1 415/4885PLAU 4558/4885 |
| US-12415951-B2 | Organic light-emitting device | EML4, ICMT, L1CAM | NOTUM 1161/4885IDO1 361/4885PLAU 3787/4885 |
| US-20030068536-A1 | Such as bis(4-biphenyl-4-yl)pyridine-C3-N3)(acetylacetonato-) iridium (III); brightness; phosphorescence; graphic arts | CYC1, CYCS, CCNA1 | NOTUM 4089/4885IDO1 47/4885PLAU 4670/4885 |
| US-12528833-B2 | Organic electroluminescent materials and devices | LBR, CHRM1, OPRD1 | NOTUM 4638/4885IDO1 1559/4885PLAU 4272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.